Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 24 November 2008, doi:10.1136/bmj.a2529
Cite this as: BMJ 2008;337:a2529
| The first 150 words of the full text of this article appear below. |
Five years ago I "lost" my husband when he had a brain haemorrhage, but as a result of medical intervention I can still visit him in his caring nursing home. With treatment for his various problems he is usually not distressed or in pain. He is no longer angry at his plight, but in place of a lucid analytical mind he is "sans everything"—with a familiar voice. Fortunately, he no longer has insight into his condition and rarely worries about his future. However, when I consider his situation and then hear about other types of patient who are denied drugs that may improve the quality of their life but that the NHS is not prepared to fund, I question the balance of its and our values and priorities.
I wrote about Michael (not his real name) in the BMJ in June 2004 (2004;328:1445, doi:10.1136/bmj.328.7453.1445) a year after a
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses